Search

Asahi Kasei Corp

Suletud

1,065 0.28

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1054

Max

1067

Põhinäitajad

By Trading Economics

Sissetulek

6.5B

28B

Müük

-622M

718B

P/E

Sektori keskmine

14.72

Aktsiakasum

16.94

Kasumimarginaal

3.86

EBITDA

9.6B

89B

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

31. juuli 2024

Järgmine aktsia dividendi kuupäev (ex-date)

26. sept 2024

Turustatistika

By TradingEconomics

Turukapital

26B

1.4T

Eelmine avamishind

1064.72

Eelmine sulgemishind

1065

Uudiste sentiment

By Acuity

18%

82%

Asahi Kasei Corp Graafik

Seotud uudised

28. mai 2024, 08:37 UTC

Omandamised, ülevõtmised, äriostud

Asahi Kasei Makes $1.1 Billion Bid For Swedish Calliditas Therapeutics -- Update

28. mai 2024, 07:17 UTC

Omandamised, ülevõtmised, äriostud

Calliditas Therapeutics Gets $1.1 Billion Takeover Bid From Asahi Kasei

Asahi Kasei Corp Prognoos

Sentiment

By Acuity

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Asahi Kasei Corp

ASAHI KASEI CORPORATION is mainly engaged in material business, housing business and others. The Company operates in three business segments. The Materials segment includes fiber business, including capra fiber, polyurethane fiber, nonwoven fabric, nylon 66 fiber, chemical business, including petrochemicals, high performance polymer, high performance materials and consumer goods, separators for lithium secondary batteries, separators for lead storage batteries, mixed signal LSI and other electronic businesses. The Housing segment includes housing business, such as construction contracting, real estate, renovation, and other housing related businesses, and the building materials business, including lightweight aerated concrete, heat insulation materials, foundation piles, structural materials. The Healthcare segment consists of pharmaceuticals such as medical drugs and diagnostics, medical business and critical care business. It also includes engineering, staffing business and others.